Cortica Has New Investment from Morgan Health, Strengthening Access to Coordinated Care for Children Living with Autism and Other Neurodevelopmental Conditions

WASHINGTON, DC —Cortica has raised an $80M round with Morgan Health and Nexus NeuroTech Ventures

• Cortica is a leading care provider for autistic and neurodivergent children, offering a "whole-child care" approach through physician-led teams of specialists including neurologists, behavior analysts, speech pathologists, physical occupational therapists and more across 24 medical home clinics in eight states.
• Morgan Health, a JPMorganChase business unit, co-led an $80 million investment in Cortica with Nexus NeuroTech Ventures, with participation from existing investor Autism Impact Fund, to help scale Cortica's services and expand access to coordinated care.
• "Families with autistic or neurodivergent children are often burdened by a highly fragmented, complex health care system. Delays in diagnosis, uncoordinated care across clinician teams and limited data to inform clinical measures leave people unsure where to turn for care or access the appropriate intervention for their child," says Dan Mendelson, CEO of Morgan Health.
• Read More Here: https://www.jpmorganchase.com/newsroom/press-releases/2024/morgan-health-cortica-investment